Table 2.
CNV calls for the RT-qPCR validated regions of 16 bladder cancer samples from Guo et al.31
Gene | Chromosome | Region Start | Region End | Call | Sample Name | XHMM | DECoNT-XHMM | ECOLE | ECOLEFT−SOMATIC |
---|---|---|---|---|---|---|---|---|---|
CDKN2A/B | 9 | 20.3 m | 24,1 m | DEL | B63_Cancer | No | No | No | Yes |
CDKN2A/B | 9 | 20.3 m | 24,1 m | DEL | B112_Cancer | Yes | Yes | No | N/A |
CDKN2A/B | 9 | 20.3 m | 24,1 m | DEL | B80-0_Cancer | No | No | No | Yes |
CCDN1 | 11 | 69.8 m | 69.8 m | DUP | B37_Cancer | No | No | No | Yes |
CCDN1 | 1 | 69.8 m | 69.8 m | DUP | B103_Cancer | No | No | No | Yes |
DHFR | 5 | 79.9 m | 80 m | DUP | B15_Cancer | No | No | No | Yes |
DHFR | 5 | 79.9 m | 80 m | DUP | B18_Cancer | No | No | No | Yes |
DHFR | 5 | 79.9 m | 80 m | DUP | B19_Cancer | No | No | No | Yes |
DHFR | 5 | 79.9 m | 80 m | DUP | B24_Cancer | No | No | No | N/A |
DHFR | 5 | 79.9 m | 80 m | DUP | B34_Cancer | No | No | No | Yes |
DHFR | 5 | 79.9 m | 80 m | DUP | B50_Cancer | No | No | No | Yes |
ERBB2 | 17 | 35 m | 35.2 m | DUP | B9_Cancer | No | No | No | Yes |
ERBB2 | 17 | 35 m | 35.2 m | DUP | B23_Cancer | No | No | No | Yes |
ERBB2 | 17 | 35 m | 35.2 m | DUP | B80_Cancer | No | No | No | N/A |
ERBB2 | 17 | 35 m | 35.2 m | DUP | B80-5_Cancer | No | No | No | Yes |
ERBB2 | 17 | 35 m | 35.2 m | DUP | B86_Cancer | No | No | No | Yes |
The table lists the genes, regions, validated calls, and the predictions of each method. Note that ECOLEFT−SOMATIC is fine-tuned on samples B112, B24, and B80. The calls of ECOLEFT−SOMATIC for these samples are denoted as N/A as they are used during training. Bold denotes captured CNV.